Literature DB >> 1627375

Surgical treatment for chest wall recurrence of breast cancer.

K Miyauchi1, H Koyama, S Noguchi, H Inaji, H Yamamoto, K Kodama, T Iwanaga.   

Abstract

From 1977 to 1987, 23 patients with isolated chest wall recurrence, excluding sternal metastasis, from breast cancer underwent full thickness chest wall resection. The 5-year survival rate after chest wall resection was 48% but the 5-year relapse-free survival rate was 26%. Mediastinal metastasis was proved histologically at the time of chest wall resection in 7 patients, and survival period with mediastinal involvement was significantly (P less than 0.01) shorter than that with no mediastinal involvement (n = 16). In 17 patients with a long disease-free interval (DFI greater than or equal to 24 months), survival was longer than in 6 patients with a short DFI (less than 24 months). For the selected patients without mediastinal involvement and long DFI, surgical treatment for chest wall recurrence of breast cancer should play a significant role in improving the quality of life, and even in prolonging the survival rate.

Entities:  

Mesh:

Year:  1992        PMID: 1627375     DOI: 10.1016/0959-8049(92)90456-c

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

1.  Full-thickness chest wall resection for locally recurrent breast cancer.

Authors:  Godehard Friedel; Thomas Kuipers; Corinna Engel; Christine Schopf; Stefanie Veit; Jutta Zoller; Thomas Kyriss; Michael Greulich; Heikki Toomes
Journal:  Thorac Surg Sci       Date:  2005-08-22

2.  Radical chest wall resection and modified reconstruction technique for solitary internal mammary lymph node recurrence in breast cancer.

Authors:  Ikram Ulhaq Chaudhry; Thabet Algazal; Zahra Alhajji; Ahsan Cheema; Hadi Al Mutairi; Fasisal Azem
Journal:  Int J Surg Case Rep       Date:  2019-04-06

3.  Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence.

Authors:  Carmen C van der Pol; Albertus N van Geel; Marian B E Menke-Pluymers; Paul I M Schmitz; Titia E Lans
Journal:  Ann Surg Oncol       Date:  2009-12       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.